KYMR
Price
$37.45
Change
-$3.17 (-7.80%)
Updated
Aug 11, 04:26 PM (EDT)
Capitalization
2.85B
Earnings call today
LQDA
Price
$20.92
Change
+$1.71 (+8.90%)
Updated
Aug 11, 04:45 PM (EDT)
Capitalization
1.75B
One day until earnings call
Interact to see
Advertisement

KYMR vs LQDA

Header iconKYMR vs LQDA Comparison
Open Charts KYMR vs LQDABanner chart's image
Kymera Therapeutics
Price$37.45
Change-$3.17 (-7.80%)
Volume$100
Capitalization2.85B
Liquidia
Price$20.92
Change+$1.71 (+8.90%)
Volume$6.69K
Capitalization1.75B
KYMR vs LQDA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. LQDA commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and LQDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (KYMR: $40.62 vs. LQDA: $19.21)
Brand notoriety: KYMR and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 116% vs. LQDA: 0%
Market capitalization -- KYMR: $2.85B vs. LQDA: $1.75B
KYMR [@Biotechnology] is valued at $2.85B. LQDA’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileLQDA’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • LQDA’s FA Score: 1 green, 4 red.
According to our system of comparison, LQDA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while LQDA’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 5 bearish.
  • LQDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both KYMR and LQDA are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а -5.45% price change this week, while LQDA (@Biotechnology) price change was +8.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 11, 2025.

LQDA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.85B) has a higher market cap than LQDA($1.75B). LQDA YTD gains are higher at: 63.350 vs. KYMR (0.969). LQDA has higher annual earnings (EBITDA): -122.53M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. LQDA (170M). KYMR has less debt than LQDA: KYMR (86.3M) vs LQDA (148M). KYMR has higher revenues than LQDA: KYMR (58.9M) vs LQDA (14.1M).
KYMRLQDAKYMR / LQDA
Capitalization2.85B1.75B163%
EBITDA-232.67M-122.53M190%
Gain YTD0.96963.3502%
P/E RatioN/AN/A-
Revenue58.9M14.1M418%
Total Cash463M170M272%
Total Debt86.3M148M58%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
28
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRLQDA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEIYX18.130.16
+0.89%
GuideStone Funds Growth Equity Idx Instl
FACGX161.471.05
+0.65%
Fidelity Advisor Growth Opps C
VCSTX37.850.21
+0.56%
VALIC Company I Science & Technology
PEXMX34.06-0.08
-0.23%
T. Rowe Price Extended Equity Market Idx
MSSCX8.64-0.02
-0.23%
AMG Frontier Small Cap Growth I

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.56%
NRIX - KYMR
67%
Closely correlated
-2.28%
VERA - KYMR
58%
Loosely correlated
+0.35%
CGON - KYMR
56%
Loosely correlated
+2.05%
LYRA - KYMR
53%
Loosely correlated
-2.76%
IDYA - KYMR
53%
Loosely correlated
+3.08%
More

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
N/A
MTVA - LQDA
44%
Loosely correlated
-1.01%
FOLD - LQDA
27%
Poorly correlated
-0.44%
KYMR - LQDA
27%
Poorly correlated
-0.56%
CERO - LQDA
26%
Poorly correlated
-1.79%
DMAC - LQDA
26%
Poorly correlated
-3.11%
More